Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-020148
Filing Date
2015-03-31
Accepted
2015-03-31 16:18:14
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v404674_10k.htm 10-K 1016681
2 EXHIBIT 23.1 v404674_ex23-1.htm EX-23.1 2125
3 EXHIBIT 31.1 v404674_ex31-1.htm EX-31.1 10781
4 EXHIBIT 31.2 v404674_ex31-2.htm EX-31.2 10613
5 EXHIBIT 32.1 v404674_ex32-1.htm EX-32.1 3961
6 EXHIBIT 32.2 v404674_ex32-2.htm EX-32.2 3896
  Complete submission text file 0001144204-15-020148.txt   10223945

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arni-20141231.xml EX-101.INS 1773092
8 XBRL TAXONOMY EXTENSION SCHEMA arni-20141231.xsd EX-101.SCH 90147
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20141231_cal.xml EX-101.CAL 50091
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20141231_def.xml EX-101.DEF 381478
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20141231_lab.xml EX-101.LAB 539531
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20141231_pre.xml EX-101.PRE 448646
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52153 | Film No.: 15739422
SIC: 2834 Pharmaceutical Preparations